LRP4, A NOVEL RECEPTOR FOR DICKKOPF 1 AND SCLEROSTIN, IS EXPRESSED BY OSTEOBLASTS AND REGULATES BONE GROWTH AND TURNOVER IN VIVO.

Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.

Lrp4 is a multifunctional member of the low density lipoprotein-receptor gene family and a modulator of extracellular cell signaling pathways in development.For example, Lrp4 binds Wise, a secreted Wnt modulator and BMP antagonist.Lrp4 shares structural elements within the extracellular ligand binding domain with Lrp5 and Lrp6, two established Wnt

read more



The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Abstract Background Multiple therapies exist for patients with metastatic castration-resistant prostate cancer (mCRPC).However, their improvement on progression-free survival (PFS) remains modest, potentially explained by tumor molecular heterogeneity.Several prognostic molecular biomarkers have been identified for mCRPC that may have predictive po

read more